AngioDynamics | ANGO - Selling And Administration Expenses

Stock Price
10.87
Daily Change
-0.12 -1.09%
Monthly
2.94%
Yearly
15.52%
Q1 Forecast
11.09

AngioDynamics reported $35.99M in Selling and Administration Expenses for its fiscal quarter ending in February of 2025.





Selling And Administration Expenses Change Date
Accuray USD 127.32M 500.16M Sep/2025
AngioDynamics USD 35.99M 14K Feb/2025
Artivion USD 50.02M 697K Sep/2024
AtriCure USD 78.34M 109K Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Inogen USD 43.77M 510K Jun/2024
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Orthofix International USD 112.21M 1.1M Sep/2024
Smiths GBP 328M 12M Dec/2025
Surmodics USD 14.58M 2.05M Sep/2024
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Trinity Biotech USD 6.19M 2.18M Sep/2025